Literature DB >> 23346507

Association of immune status with recurrent anal condylomata in human immunodeficiency virus-positive patients.

Ji Hyun Sung1, Eun Jung Ahn, Heung-Kwon Oh, Sei Hyeog Park.   

Abstract

PURPOSE: An anal condyloma is a proliferative disease of the genital epithelium caused by the human papillomavirus. This condition is most commonly seen in male homosexuals and is frequently recurrent. Some reports have suggested that immunosuppression is a risk factor for recurrence of a condyloma. Thus, we investigated the risk factors for a recurrent anal condyloma in human immunodeficiency virus (HIV)-positive patients.
METHODS: We retrospectively analyzed 85 consecutive patients who were diagnosed with and underwent surgery for an anal condyloma from January 2007 to December 2011. Outcomes were analyzed based clinical and immunologic data.
RESULTS: Recurrent anal condylomata were found in 25 patients (29.4%). Ten cases (40.0%) were within postoperative 3 months. At postoperative 6 months, the CD4 lymphocyte count in the recurrent group was lower than it was in the nonrecurrent group (P = 0.023).
CONCLUSION: CD4-mediated immunosuppression is a risk factor for recurrent anal condylomata in HIV-positive patients.

Entities:  

Keywords:  Condyloma accuminata; HIV; Human papillomavirus; Immunosuppression; Recurrence

Year:  2012        PMID: 23346507      PMCID: PMC3548143          DOI: 10.3393/jksc.2012.28.6.294

Source DB:  PubMed          Journal:  J Korean Soc Coloproctol        ISSN: 2093-7822


  14 in total

1.  Preoperative immune status determines anal condyloma recurrence after surgical excision.

Authors:  Sebastian G de la Fuente; Kirk A Ludwig; Christopher R Mantyh
Journal:  Dis Colon Rectum       Date:  2003-03       Impact factor: 4.585

Review 2.  Human papillomavirus and human disease.

Authors:  K R Beutner; S Tyring
Journal:  Am J Med       Date:  1997-05-05       Impact factor: 4.965

3.  Verrucous carcinoma of the foot associated with human papillomavirus type 16.

Authors:  B J Schell; T Rosen; P Rády; I Arany; J A Tschen; M F Mack; S K Tyring
Journal:  J Am Acad Dermatol       Date:  2001-07       Impact factor: 11.527

4.  Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia.

Authors:  A A Gaspari; A D Zalka; D Payne; M Menegus; L A Bunce; C N Abboud; S K Tyring
Journal:  Arch Dermatol       Date:  1997-04

5.  Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls.

Authors:  Giuseppe De Panfilis; Giulia Melzani; Giovanni Mori; Alessandra Ghidini; Severo Graifemberghi
Journal:  Sex Transm Dis       Date:  2002-03       Impact factor: 2.830

6.  Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus.

Authors:  P L Breese; F N Judson; K A Penley; J M Douglas
Journal:  Sex Transm Dis       Date:  1995 Jan-Feb       Impact factor: 2.830

7.  Immunostimulation to reduce recurrence after surgery for anal condyloma acuminata: a prospective randomized controlled trial.

Authors:  M Mistrangelo; S Cornaglia; M Pizzio; R Rimonda; G Gavello; I Dal Conte; A Mussa
Journal:  Colorectal Dis       Date:  2009-06-22       Impact factor: 3.788

8.  Immunosuppression may be present within condyloma acuminata.

Authors:  Caroline Le Poole; Cecele J Denman; Jack L Arbiser
Journal:  J Am Acad Dermatol       Date:  2008-12       Impact factor: 11.527

9.  Risk factors for incident and recurrent condylomata acuminata among women. A population-based study.

Authors:  L A Habel; S K Van Den Eeden; K J Sherman; B McKnight; A Stergachis; J R Daling
Journal:  Sex Transm Dis       Date:  1998-07       Impact factor: 2.830

10.  Risk factors for incident and recurrent condylomata acuminata among men. A population-based study.

Authors:  S K Van Den Eeden; L A Habel; K J Sherman; B McKnight; A Stergachis; J R Daling
Journal:  Sex Transm Dis       Date:  1998-07       Impact factor: 2.830

View more
  3 in total

1.  Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men.

Authors:  Sandra Vela; Sebastian Videla; Arelly Ornelas; Boris Revollo; Bonaventura Clotet; Guillem Sirera; Marta Piñol; Francesc García-Cuyás
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

2.  Comparison of Plasma Zinc Levels Among HIV+ and HIV- Subjects Infected with Condyloma Acuminata

Authors:  Anak Agung Gde Putra Wiraguna; Putu Indah Andriani; Made Swastika Adiguna
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

3.  Efficacy of fulguration combined with imiquimod cream on condyloma acuminatum, and the effect on immune functions and serums levels of IL-2 and IL-10.

Authors:  Quan Chen; Ridong Yang; Aili Gao; Daoqing Zhong; Huilan Zhu
Journal:  Exp Ther Med       Date:  2017-05-09       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.